All Stories

  1. An update on arginine in sickle cell disease

    Article • Expert Review of Hematology, March 2019, Taylor & Francis

    Dr Bruno Deltreggia Benites

  2. The challenges of handling deferasirox in sickle cell disease patients older than 40 years

    Article • Hematology, January 2019, Taylor & Francis

    Dr Bruno Deltreggia Benites

  3. Implementing a patient blood management programme in Brazil: challenges and implications for developing countries

    Article • ISBT Science Series, May 2018, Wiley

    Dr Bruno Deltreggia Benites

  4. Deferasirox associated with liver failure and death in a sickle cell anemia patient homozygous for the −1774delG polymorphism in the Abcc2 gene

    Article • Clinical Case Reports, June 2017, Wiley

    Dr Bruno Deltreggia Benites

  5. Exchange transfusion during pregnancy of sickle hemoglobin C disease patients

    Article • Transfusion, September 2015, Wiley

    Dr Bruno Deltreggia Benites

  6. Obesity and inflammation and the effect on the hematopoietic system

    Article • Revista Brasileira de Hematologia e Hemoterapia, March 2014, Elsevier

    Dr Bruno Deltreggia Benites

  7. MDR-1 and GST polymorphisms are involved in myelodysplasia progression

    Article • Leukemia Research, August 2013, Elsevier

    Dr Bruno Deltreggia Benites

  8. Primary myelofibrosis: risk stratification by IPSS identifies patients with poor clinical outcome

    Article • Clinics, March 2013, Fundacao Faculdade de Medicina

    Dr Bruno Deltreggia Benites

  9. Increased expression of APAF-1 in low-risk myelodysplastic syndrome: a possible role in the pathophysiology of myelodysplasia

    Article • European Journal Of Haematology, May 2010, Wiley

    Dr Bruno Deltreggia Benites

  10. Low expression of APAF-1XL in acute myeloid leukemia may be associated with the failure of remission induction therapy

    Article • July 2008, FapUNIFESP (SciELO)

    Dr Bruno Deltreggia Benites